R Ramakrishnan

Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.

Katriina Aalto‐Setälä, Edward A. Fisher, X Chen et al. · Journal of Clinical Investigation · 1992 · 455 citations · Full text

Hyperlipidemia, Low Density, Oxidative Stress +19

Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol.

Bernard Horowitz, Ira J. Goldberg, J Merab et al. · Journal of Clinical Investigation · 1993 · 231 citations · Full text

Low Hdl Cholesterol, Apolipoprotein A-i, Hyperlipidemia +16

Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis.

Henry N. Ginsberg, Ngoc‐Anh Le, M. Priscilla Short et al. · Journal of Clinical Investigation · 1987 · 202 citations · Full text

Free Cholesterol, Hyperlipidemia, Cholesterol Synthesis +16

Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.

Tetsu Ebara, R Ramakrishnan, George Steiner et al. · Journal of Clinical Investigation · 1997 · 189 citations · Full text

Hyperlipidemia, Apoe0 Mice, Oxidative Stress +20

Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice.

Neil S. Shachter, Tony Hayek, Todd Leff et al. · Journal of Clinical Investigation · 1994 · 136 citations · Full text

Transgene Expression, Hyperlipidemia, Oxidative Stress +20